A Novel Aldosterone Antagonist Limits Renal Injury in 5/6 Nephrectomy (2017)
- Authors:
- USP affiliated authors: FUJIHARA, CLARICE KAZUE - FM ; RODRIGUES, MARILIZA VELHO - FM ; FANELLI, CAMILLA - FM ; MALHEIROS, DENISE MARIA AVANCINI COSTA - FM ; KRIEGER, JOSE EDUARDO - FM ; ZATZ, ROBERTO - FM
- Unidade: FM
- DOI: 10.1038/s41598-017-08383-2
- Subjects: RATOS WISTAR; INSUFICIÊNCIA RENAL CRÔNICA; FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO
- Language: Inglês
- Imprenta:
- Publisher place: United Kingdom
- Date published: 2017
- Source:
- Título: Scientific Reports
- ISSN: 2045-2322
- Volume/Número/Paginação/Ano: v. 7, n. 7733, p. 1-12, 2017
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
FUJIHARA, Clarice K. et al. A Novel Aldosterone Antagonist Limits Renal Injury in 5/6 Nephrectomy. Scientific Reports, v. 7, n. 7733, p. 1-12, 2017Tradução . . Disponível em: https://doi.org/10.1038/s41598-017-08383-2. Acesso em: 04 mar. 2026. -
APA
Fujihara, C. K., Kowala, M. C., Breyer, M. D., Sena, C. R., Rodrigues, M. V., Arias, S. C. A., et al. (2017). A Novel Aldosterone Antagonist Limits Renal Injury in 5/6 Nephrectomy. Scientific Reports, 7( 7733), 1-12. doi:10.1038/s41598-017-08383-2 -
NLM
Fujihara CK, Kowala MC, Breyer MD, Sena CR, Rodrigues MV, Arias SCA, Fanelli C, Malheiros DM, Jadhav PK, Montrose-Rafizadeh C, Krieger JE, Zatz R. A Novel Aldosterone Antagonist Limits Renal Injury in 5/6 Nephrectomy [Internet]. Scientific Reports. 2017 ; 7( 7733): 1-12.[citado 2026 mar. 04 ] Available from: https://doi.org/10.1038/s41598-017-08383-2 -
Vancouver
Fujihara CK, Kowala MC, Breyer MD, Sena CR, Rodrigues MV, Arias SCA, Fanelli C, Malheiros DM, Jadhav PK, Montrose-Rafizadeh C, Krieger JE, Zatz R. A Novel Aldosterone Antagonist Limits Renal Injury in 5/6 Nephrectomy [Internet]. Scientific Reports. 2017 ; 7( 7733): 1-12.[citado 2026 mar. 04 ] Available from: https://doi.org/10.1038/s41598-017-08383-2 - An association of losartan-hydrochlorothiazide, but not losartan-furosemide, completely arrests progressive injury in the remnant kidney
- Effects of losartan, in monotherapy or in association with hydrochlorothiazide, in chronic nephropathy resulting from losartan treatment during lactation
- Associação terapêutica de losartan (L) e hidroclorotiazida (H) previne progressão da lesão renal em modelo de nefropatia crônica resultante da administração de (L) durante a lactação
- Furosemide (F) is less effective than hydroclorothiazide (H) as adjuvant to losartan (L) in arresting the nephropathy associated with the 5/6 renal ablation model (NX)
- Losartan (L) and hydrochlorotiazide (H) association (LH) arrests renal inhury in a model of very advanced chronic kidney disease (CKD)
- Losartan (L) and Hydrochlorothiazide (H)Treatment (LH) arrests renal and cardiac injury in advanced chronic kidney disease by mechanisms not entireky dependent on blood pressure
- Renoprotective effect of two dosages of Losartan (L) in a model of crhonic kidney disease (CDK) by nitric oxide inhibition and and salt overload
- Mechanisms of progressive renal injury in adult rats treated with losartan during lactation
- Pathogenic role of innate immunity in a model of chronic NO inhibition associated with salt overload
- TLR2 and TLR4 play opposite role in autophagy associated with cisplatin-induced acute kidney injury
Informações sobre o DOI: 10.1038/s41598-017-08383-2 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
